Technical Analysis for ALGS - Aligos Therapeutics, Inc.

Grade Last Price % Change Price Change
B 32.85 -3.95% -1.35
ALGS closed down 3.95 percent on Friday, January 22, 2021, on 37 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Up Flat
Historical ALGS trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup -3.95%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.95%
Inside Day Range Contraction -3.95%
Wide Bands Range Expansion -3.95%
Upper Bollinger Band Touch Strength -3.95%
Older End-of-Day Signals for ALGS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
10 DMA Support 1 day ago
Down 5% 1 day ago
Down 3% 1 day ago
Down 2 % 1 day ago
Down 1% 1 day ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of viral infections and liver diseases. Aligos is focused on the development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). Aligos’ strategy is to harness the deep expertise and decades of drug development experience its workforce has in liver disease, particularly viral hepatitis, to rapidly advance its pipeline of potentially best-in-class molecules.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Alcohol Drug Development Coronavirus Hepatitis B Viruses Steatohepatitis Hepatitis Liver Disease Infectious Causes Of Cancer Non Alcoholic Fatty Liver Disease Liver Diseases Healthcare Associated Infections Viral Diseases Viral Infection Chronic Hepatitis Viral Infections Antiviral Therapies Chronic Hepatitis B

Is ALGS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 37.465
52 Week Low 12.82
Average Volume 199,535
200-Day Moving Average 0.00
50-Day Moving Average 24.41
20-Day Moving Average 30.72
10-Day Moving Average 32.71
Average True Range 3.22
ADX 49.94
+DI 28.22
-DI 11.28
Chandelier Exit (Long, 3 ATRs ) 27.81
Chandelier Exit (Short, 3 ATRs ) 34.31
Upper Bollinger Band 36.10
Lower Bollinger Band 25.34
Percent B (%b) 0.7
BandWidth 35.03
MACD Line 2.73
MACD Signal Line 2.81
MACD Histogram -0.0787
Fundamentals Value
Market Cap 1.15 Billion
Num Shares 35 Million
EPS
Price-to-Sales 0.00
Price-to-Book 5.43
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 35.61
Resistance 3 (R3) 35.71 34.88 35.15
Resistance 2 (R2) 34.88 34.18 34.84 35.00
Resistance 1 (R1) 33.87 33.75 33.46 33.77 34.84
Pivot Point 33.04 33.04 32.84 33.00 33.04
Support 1 (S1) 32.03 32.34 31.62 31.93 30.86
Support 2 (S2) 31.20 31.91 31.16 30.70
Support 3 (S3) 30.19 31.20 30.55
Support 4 (S4) 30.09